Navigation Links
Shire Successfully Settles Former TKT Shareholder Appraisal Rights Litigation
Date:11/5/2008

PHILADELPHIA and DUBLIN, November 5 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces that it has successfully settled all pending litigation in connection with former dissenting shareholders of Transkaryotic Therapies, Inc. (TKT). Shire will pay the same price of $37 per share originally offered to all TKT shareholders at the time of the July 2005 merger, plus interest.

Background to the litigation

As previously disclosed, before completion of the merger, certain dissenting shareholders holding approximately 11.3 million of TKT shares submitted written demands for appraisal of the fair value of these shares and, as a result, elected not to accept the $37 per share merger consideration offered by Shire. A second lawsuit was brought in March 2007 alleging, among other claims, breaches of fiduciary duty by certain members of TKT's Board. The majority of that second lawsuit had been dismissed by the Court at summary judgment in June 2008. A trial date had been set for both cases on December 10th, 2008.

Details of the Settlement

Shire will pay $37 per share - the same amount per share paid to non-dissenting shareholders in July 2005 at the time of the merger between Shire and TKT - plus interest. The Delaware Chancery Court has approved dismissal of the case and Shire expects to make payment to the dissenting shareholders on November 7, 2008.

The settlement represents a total payment of $567.5 million, representing consideration at $37 per share of $419.9 million and an interest cost of $147.6m. Although not controlling for this case, under current law, the court presumptively awards interest in appraisal rights cases at a statutorily determined interest rate that is 5 percentage points above the Federal Reserve discount rate (as it varies over the duration of the case). The interest cost for today's settlement uses an interest rate that approximates this sta
'/>"/>

SOURCE Shire Plc
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Shire Appoints Sylvie Gregoire President of Human Genetic Therapies Business
2. Shires ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome
3. Shire Divests Non-Core Product Portfolio to Almirall
4. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
5. David Mott Appointed Non Executive Director at Shire
6. Shire plc: Board Changes
7. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
8. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
9. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
10. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
11. Shire Engages Palio

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., DURHAM, N.C., Nov. 27 Cromoz Inc...e water-soluble carbon nanotube-based cancer drug ...uble carbon nanotubes, which have functional group...ncer drugs, was developed in partnership with the ...arbon nanotubes serves as a drug delivery vehicle ...
(Date:11/25/2009)..., BOSTON, Nov. 25 Biotech firm Rep...nomic data from the 1918 pandemic through the pred... pandemic, today issued its latest biochemical ana...thality of the H1N1 ("Swine Flu") virus has droppe...,s current outbreak in the spring of 2009 to resti...
(Date:11/25/2009)..., NEW YORK, Nov. 25 Reportlinker.c...available in its catalogue: ,, Brazil Bioethan...ttp://www.reportlinker.com/p0165503/Brazil-Bioetha..., Brazil Bioethanol Market Analysis and Forecast...s detailed analysis and forecasts of the global bi...
(Date:11/24/2009)... The New York investment bank KTA Capital... agreed an AU$6.7 mil convertible note private pla...vate placement was arranged by KTA Capital as Neur... New York (PRWEB) November 23,...KTA Capital, LLC ("KTA Capital") has ann...
Breaking Biology Technology:North Carolina Based Cromoz Inc. Launches Carbon Nanotechnology for Target Drug Delivery System in Cancer Treatment in Hyderabad, India 2Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 10KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2
... SAN DIEGO, May 27 Accumetrics, Inc. announces to...ments for its VerifyNow(R) System in several Europ...yNow products will be handled by AAZ in France; BI... Kordia in the Netherlands, Belgium and Luxembourg...saving antiplatelet therapies, such as aspirin, Pl...
... , , Technology to Drive Production Efficiency ...n Germany , , OFFENBACH, Germany, May 27 Honey...en selected by B. Braun, a leading global manufact...ntrol solutions for a new factory that will produc...s. The Leading Infusion Factory Europe (LIFE) Nutr...
... MENLO PARK, Calif., May 27 ForteBio(R), Inc., a ...elerates the development of biotherapeutic and pha...launched two new assay modules - for high-sensitiv...espectively - for use on the company,s Octet(R) in...ble via software upgrades and will enable, for the...
Other Biology Technology:Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg 2Accumetrics, Inc. Announces European Distribution Channels for France, Austria, Switzerland, Netherlands, Belgium and Luxembourg 3Honeywell to Help B. Braun Healthcare Company Double Manufacturing Capacity of Life-Critical Products 2Honeywell to Help B. Braun Healthcare Company Double Manufacturing Capacity of Life-Critical Products 3Honeywell to Help B. Braun Healthcare Company Double Manufacturing Capacity of Life-Critical Products 4ForteBio Launches New Assay Capabilities for High-Sensitivity Protein Quantitation and Fragment Screening on Its Octet(R) Platform 2
(Date:11/24/2009)...UGE Antarctica has long held secrets of the earth...ently, there has been very little information on t...s of ice for millions of years. Now, a team of res...ve been funded to the tune of $10 million dollars ... to the bottom of things literally. These scienti...
(Date:11/23/2009)..., D.C. The community-associated strain of the dea...istant to most common antibioticsposes a far great...ng its way into hospitals, according to a study in...es . , The new threat is easily picked up in fi...d has increased the overall burden of MRSA within ...
(Date:11/23/2009)..., CT Current research suggests that a common oral... related report by Nichols et al, "Unique Lipids f... of TLR2 Ligands Capable of Enhancing Autoimmunity...ican Journal of Pathology . , Multiple sclerosis...he brain and spinal cord, affects nearly 1 in 700 ...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 1Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 2Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 3Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 4Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 5Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 6Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 7Reportlinker Adds The World Market for Gastrointestinal Endoscopy Equipment Report 57996 8Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post Launch 3A Contract Manufacturing and Contract Sales and Marketing 3rd Edition Report 57993 1Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post Launch 3A Contract Manufacturing and Contract Sales and Marketing 3rd Edition Report 57993 2Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post Launch 3A Contract Manufacturing and Contract Sales and Marketing 3rd Edition Report 57993 3Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post Launch 3A Contract Manufacturing and Contract Sales and Marketing 3rd Edition Report 57993 4Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post Launch 3A Contract Manufacturing and Contract Sales and Marketing 3rd Edition Report 57993 5Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post Launch 3A Contract Manufacturing and Contract Sales and Marketing 3rd Edition Report 57993 6Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post Launch 3A Contract Manufacturing and Contract Sales and Marketing 3rd Edition Report 57993 7Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post Launch 3A Contract Manufacturing and Contract Sales and Marketing 3rd Edition Report 57993 8Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post Launch 3A Contract Manufacturing and Contract Sales and Marketing 3rd Edition Report 57993 9Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post Launch 3A Contract Manufacturing and Contract Sales and Marketing 3rd Edition Report 57993 10Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post Launch 3A Contract Manufacturing and Contract Sales and Marketing 3rd Edition Report 57993 11Reportlinker Adds Pharmaceutical Outsourcing Opportunities Post Launch 3A Contract Manufacturing and Contract Sales and Marketing 3rd Edition Report 57993 12Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 1Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 2Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 3Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 4Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 5Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 6Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 7Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 8Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 9Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 10Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 11Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 12Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 13Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 14Reportlinker Adds Omega Fatty Acids 3A Trends in the Worldwide Food and Beverage Markets 2nd Edition Report 57990 15
...ssue of The Journal of Experimental Medicine, a gr...nsley may have discovered how a normally harmless ...threatening meningitis. , The human body harbors m...als. One such bacterium, called Neisseria meningit...t, usually without consequence. But certain strain...
...octors, or Sultans of Soil, they,re just clever La... has a paper in this week,s Science Magazine with ..., in the highly complex world beneath our feet. , ... Diversity and High Metal Toxicity in Soil," by Ja...Alamos, Bioscience Division, describes a new appro...
...her to be sperm or eggs , Johns Hopkins biologist...r specialized "germ cells" whether to develop into...oth male and female embryos, germ cells are the pr..." on their own which to become, however, germ cell...os as to which is the appropriate sex. The Johns H...
Other Biology News:Using computers and DNA to count bacteria 2Decisions, decisions: Male or female? 2
Custom Conjugation Services from SoluLink
... ATPase α-1, clone C464.6 GenBank Accession.../K + ATPase isolated from membrane fractions of r...glycine, pH 7.4, 0.15M NaCl containing 0.05% sodiu...immunoblot on rat brain microsomal preparations Re...
Mouse Anti-Human PSGL-1 Monoclonal Antibody, Unconjugated, Clone 215 from Santa Cruz Biotechnology, Inc.
Mouse Anti-Adenovirus Type 7 hexon C11 Monoclonal Antibody, Unconjugated, Clone 1-N-14 from GeneTex
Biology Products: